Adverse Reaction to Drug Recruiting Phase Trials for Mirtazapine (DB00370)

IndicationStatusPhase
DBCOND0042486 (Adverse Reaction to Drug)RecruitingNot Available
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00817375Pharmacogenomic Study to Predict Antidepressant Responsiveness in Depressed PatientsTreatment